Seer to Present at the BofA Securities 2021 Healthcare Conference

Rhea-AI Summary

Seer, a life sciences company known for its innovative proteomics platform, announced participation in the BofA Securities 2021 Healthcare Conference. The event will take place virtually on May 13 at 10:15 a.m. PT and will feature a fireside chat with management. Investors can access the live webcast through the Investor section of Seer’s website, with an archived replay available afterward. Seer's Proteograph Product Suite offers advanced, unbiased proteomic analysis, designed for use in various laboratories.

REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will be participating virtually in the upcoming BofA Securities 2021 Healthcare Conference.

Seer’s management is scheduled to participate in a fireside chat on Thursday, May 13 at 10:15 a.m. Pacific Time / 1:15 p.m. Eastern Time. A live webcast of the virtual session will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the conference.

About Seer
Seer is a life sciences company developing transformative products that open up a new gateway to the proteome. Seer is commercializing its Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy-to-use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be adopted by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.

Investor Contact
Carrie Mendivil
investor@seer.bio 

Media Contact
Karen Possemato
pr@seer.bio 

FAQ

When is Seer's participation in the BofA Securities 2021 Healthcare Conference?

Seer will participate on May 13, 2021, at 10:15 a.m. Pacific Time.

How can I watch Seer's presentation at the healthcare conference?

You can watch the live webcast on Seer’s Investor website at investor.seer.bio.

What is the focus of Seer's Proteograph Product Suite?

The Proteograph Product Suite focuses on providing deep, unbiased proteomic analysis at scale.

Is Seer's Proteograph Product Suite intended for diagnostic use?

No, it is for research use only and not intended for diagnostic procedures.

Where can I find more information about Seer?

More information about Seer can be found on their official website at www.seer.bio.